These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3079156)

  • 21. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract]   [Full Text] [Related]  

  • 22. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody.
    Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
    Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667
    [No Abstract]   [Full Text] [Related]  

  • 23. Flow cytometry analysis of increased expression of LFA-1/ICAM-1 in TCR-positive lymphocytes infiltrating cardiac allografts in rats.
    Tsuchida M; Hirahara H; Hirono T; Hanawa H; Matsumoto Y; Abo T; Eguchi S
    Transplant Proc; 1994 Dec; 26(6):3727-30. PubMed ID: 7998330
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL; Barrett LV; Koltun WA; Diamantstein T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.
    Sido B; Morris PJ; Dallman M
    Transplant Proc; 1992 Dec; 24(6):2549-50. PubMed ID: 1465862
    [No Abstract]   [Full Text] [Related]  

  • 27. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
    Paul LC; Davidoff A; Benediktsson H; Issekutz TB
    Transplantation; 1993 May; 55(5):1196-9. PubMed ID: 8497903
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61).
    Schweizer E; Papachrysanthou A; Faendrich F; Deltz E; Schroeder P
    Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
    Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M
    Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival.
    Heidecke CD; Hancock WW; Jakobs F; Westerholt S; Sewzcik T; Deusch K; Zantl N; Kurrle R; Kupiec-Weglinski J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):540-2. PubMed ID: 8438405
    [No Abstract]   [Full Text] [Related]  

  • 37. Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
    Kupiec-Weglinski JW; van der Meide P; Stunkel KG; Tanaka K; Diamantstein T; Tilney NL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):992-3. PubMed ID: 2495637
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
    Masaki Y; Oohara T; Shinomiya T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract]   [Full Text] [Related]  

  • 40. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.